Hodgkin’s lymphoma, a cancer originating from White Blood Cells can now be cured using a revolutionary medicine name Nivolumab. A clinical trial was conducted on lymphoma patients that were treated with this drug. The drug had a promising effect on about 87 percent of the patients.
The drug de facto allows body’s immune system to enhance, track and destroy the cancerous cells. At the end of these trials the tumors were partially exonerate.